Scientific exchange · Dr. Zoë Bauer

24 Jun 2026 · Virtual · Dr. Zoë Bauer, McGill University Health Centre · MSL Luis Ortega · Lumeva

ReviewedManualENG-0167—

Capture insight from this engagement

Location: McGill University Health Centre
Therapeutic area: Neurology
Country: Canada
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: LOLuis OrtegaMSL, Neurology (Iberia)
Product: Lumeva (lumevarin)

Topics discussed

Chronic migraine data
Real-world persistence
Medication-overuse headache

Scientific content used

CGRP class review
Chronic migraine scientific platform

Questions raised

What is the persistence rate at 18 months in real-world cohorts?
Any data in patients with medication-overuse headache?

Notes

Scientific exchange with primary care physician at McGill University Health Centre. Discussed chronic migraine data, real-world persistence, medication-overuse headache.

Insights captured (1)

Capture insight

INS-0021High
Chronic migraine data
Chronic migraine data: practice variation observed reported by primary care physician (CA).
Outcome recorded

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

No follow-ups recorded.

Quality ratings

1–5, rated at review

Scientific relevance: 5
Strategic relevance: 4
Depth of exchange: 1
Actionability: 2

Data lineage

Source system: Manual
Sync: Entered manually in Hub
System of record: Hub
Record id: ENG-0167

Audit history (0)

All create, update and approval events for this record

No audit events in sample data